About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs

Docs on Twitter


Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Conference & CLE Calendar | Main | Sigma-Aldrich Joins the CRISPR Interference Fray »

December 12, 2021

Comments

Why would the Executive Branch deign to answer the Legislative Branch here?

What would make the fifth attempt any more compelling than the first four?

I agree with Sen. Tillis that IP is not the “rate limiting” force slowing down vaccine deployment, really anywhere in the world. That said, it betrays a certain misunderstanding of the stakes when one “urge[s] the Administration to abandon… attempts to… waive… American intellectual property (IP) rights… .” At no point has this administration advocated for waiving US IP rights. Rather, the point in contention is whether IN might be allowed to waive IN IP rights, or ZA might be allowed to waive ZA IP rights.

Incidentally, what does it mean to speak of “American… IP… rights—at home or abroad”? How can “American IP rights” be anywhere other than “at home.” If you are talking about IP rights abroad, then they are not—by definition—“American” IP rights.

For whatever odd reason, I see that Mr. DeLassus insists on his disinformation campaign.

Well, the reason is not all that odd, seeing how his cognitive dissonance between Big Pharma and Liberal Left is well recognized (by all but him, it appears).

The comments to this entry are closed.

May 2022

Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31